Olfactory neuroblastoma: Long-term clinical outcome at a single institute between 1979 and 2003

Acta Oto-Laryngologica

Volumn 127, Issue SUPPL. 559, 2007, Pages 113-117

  Nakao, Kazunari ^a   Watanabe, Kenta ^a   Fujishiro, Yoshinori ^a   Ebihara, Yasuhiro ^a   Asakage, Takahiro ^a   Goto, Akiteru ^a   Kawahara, Nobutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Craniofacial resection; Hyams' histopathological grade; Kadish classification; Long term outcome; Olfactory neuroblastoma; Prognostic factors

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOFACIAL SURGERY; DISEASE FREE SURVIVAL; ESTHESIONEUROBLASTOMA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; NECK METASTASIS; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 40749085694     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/03655230701599982     Document Type: Article

References (14)

1. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976;37:1571-6.
2. Diaz EM, Johnigan RH, Pero C, El-Naggar AK, Roberts DB, Barker JL, et al. Olfactory neuroblastoma. The 22-year experience at one comprehensive cancer center. Head Neck 2005;27:138-49.
3. Chao KS, Kaplan C, Simpson JR, Haughey B, Spector GJ, Sessions DG, et al. Esthesioneuroblastoma: the impact of treatment modality. Head Neck 2001;23:749-57.
4. Dias FL, Sa GM, Lima RA, Kligerman J, Leoncio MP, Freitas EQ, et al. Patterns of failure and outcome in esthesioneuroblastoma. Arch Otolaryngol Head Neck Surg 2003;129:1186-92.
5. Deviaiah AK, Larsen C, Tawfik O, O'Boynick P, Hoover LA. Esthesioneuroblastoma: endoscopic nasal and anterior craniotomy resection. Laryngoscope 2003;113:2086-90.
6. Yuen AP, Fan YW, Fung CF, Hung KN. Endoscopic-assisted cranionasal resection of olfactory neuroblastoma. Head Neck 2005;27:488-93.
7. Wang CC, Chen YL, Hsu YS, Hao SP. Transcranial resection of olfactory neuroblastoma. Skull Base 2005;15:163-71.
8. Theilgaard SA, Buchwald C, Ingeholm P, Larsen SK, Eriksen JG, Hansen HS. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Otolaryngol (Stockh) 2003;123:433-9.
9. Kim DW, Jo YH, Kim JH, Wu HG, Rhee CS, Lee CH, et al. Neoadjuvant etoposide, Ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma. Cancer 2004;101:2257-60.
10. Dulguerov P, Allal AS, Calcaterra TC. Esthesioneuroblastoma: a meta-analysis and review. Lancet Oncol 2001;2:683-90.
11. Constantinidis J, Steinhart H, Koch M, Buchfelder M, Schaenzer A, Weidenbecher M, et al. Olfactory neuroblastoma. The University of Erlangen-Nuremberg experience 1975-2000. Otolaryngol Head Neck Surg 2004;130:567-74.
12. Hwang SK, Paek SH, Kim DG, Jeon YK, Chi JG, Jung HW. Olfactory neuroblastoma: survival rate and prognostic factor. J Neurooncol 2002;59:217-26.
13. Lund VJ, Howard D, Wei W, Spittle M. Olfactory neuroblastoma: past, present, and future? Laryngoscope 2003;113:502-7.
14. Morris L, Govindaraj S, Genden EM. Primary sphenoid sinus esthesioneuroblastoma. Am J Otolaryngol 2004;25:350-3.